biotech

MedImmune Considers Sale

Filed in archive Corporate and Industrial News on April 13, 2007

MedImmune Considers Sale
MedImmune, the makers of the inhaled influenza vaccine FluMist, is considering acquisition offers from third parties. It has hired Goldman Sachs & Co. and the law firm Dewey Ballantine to help with a possible sale.
[snip].. indications of interest by major pharmaceutical companies, coupled with recent expressions by certain stockholders of dissatisfaction with the company's short-term stock price performance, have led the board to authorize management to gather information regarding possible strategic interest in acquiring the company.


More backgrounder info from Chron.com.

Permalink: MedImmune Considers Sale

Tags: MedImmune  investment  pharma  pharmaceutical  vaccine  FluMist  biotech  considers+sale 

Vote for MedImmune Considers Sale:

  • Currently 9.50/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 9.50 out of 2 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Most Popular   Best of   Biotech Hubs and Facilities   Biotech/Science Blogs   Corporate and Industrial News   Diagnostics, Methodologies and Instrumentation   Did you know   Drugs, Vaccines and Therapeutics   Energy, Environment and Ecology   Food and Agriculture   Gene Therapy   Genomics, Proteomics and Bioinformatics   Information About   Meetings and Other Events   Microbiology   Misc   Nanomedicine   Other Biotechnology News   Patents and Intellectual Property Rights   Quick introduction   Stem Cells